Clinical Trial Update: Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy [Phase 3]

View source ↗

Summary

Clinical trial update reporting efficacy and safety results for balaglitazone in patients with type 2 diabetes on stable insulin therapy (Phase 3, completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Balaglitazone (balaglitazone)

Snippet

Sponsor: Rheoscience A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED